Iyer, S. P., Jagadeesh, D., Domingo-Domenech, E., Benedetti, F., Izquierdo, A. R., Bouabdallah, K., Vitolo, U., Illidge, T., Liu, J., Shaikh, E., Horwitz, S. M. (2025). Frontline brentuximab vedotin (BV) and CHP in patients (pts) with peripheral T-cell lymphoma (PTCL) with <10% CD30 expression: Primary analysis results from the phase 2 SGN35-032 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7077